Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Long-Term Investments (2024 - 2025)

Historic Long-Term Investments for Praxis Precision Medicines (PRAX) over the last 2 years, with Q3 2025 value amounting to $122.0 million.

  • Praxis Precision Medicines' Long-Term Investments rose 12535.23% to $122.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.0 million, marking a year-over-year increase of 12535.23%. This contributed to the annual value of $77.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Praxis Precision Medicines reported Long-Term Investments of $122.0 million as of Q3 2025, which was up 12535.23% from $145.4 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Long-Term Investments registered a high of $145.4 million during Q2 2025, and its lowest value of $35.9 million during Q1 2024.